The Directory of Pharma Companies and News


Recipharm logo
Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 2,200 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material including API and pharmaceutical product development. Recipharm manufactures more than 400 different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm�s turnover is approximately SEK 3.3 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For more information on Recipharm and our services, please visit
Category: Manufacturing
Category: Manufacturing

Recipharm News

2016-01-26Recipharm completes a directed issue of 2.25 million Class B shares, raising proceeds of approximately SEK 276 million (PDF)
2016-01-20Recipharm appoints new Key Account Director for Europe (PDF)
2016-01-15Regulatory approval received for acquisition of Nitin Lifesciences (PDF)
2016-01-08Recipharm appoints General Manager for its new Blow Fill Seal subsidiary in Kaysersberg, France (PDF)
2015-12-21Recipharm signs manufacturing agreement with Alcon and acquires facility in France, adding new niche capabilities (PDF)
2015-12-15Recipharm and LIDDS sign contract for production of Liproca® Depot and investment in LIDDS (PDF)
2015-11-10Recipharm secures €25 million contract for Erdosteine API with Daewoong Pharmaceutical (PDF)
2015-11-05Interim report January - September 2015 (PDF)
2015-11-03Invitation to presentation of Recipharm’s interim report for the third quarter on 5 November 2015 (PDF)
2015-10-22Recipharm appoints new Business Director for Italy and new General Manager at Pessac, France (PDF)
2015-10-20Recipharm to acquire majority stake in Indian CMO Nitin Lifesciences creating Emerging Markets platform (PDF)
2015-10-08Recipharm announces cost and efficiency program in Sweden (PDF)
2015-10-02XSpray Microparticles receives 18 million SEK investment to finance clinical development of its lead compound XS004 (PDF)
2015-09-08Recipharm reaches agreement with LobSor Pharmaceuticals to manufacture LECIGON (TM), a proprietary treatment for advance... (PDF)
2015-09-07Recipharm in discussions with Alcon regarding long-term manufacturing agreement (PDF)
2015-08-26Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection (PDF)
2015-07-23Interim report January-June 2015 (PDF)
2015-07-20Invitation to presentation of Recipharm’s interim report for the first quarter on 23 July 2015 (PDF)
2015-07-13Recipharm secures additional bank financing for continued growth (PDF)
2015-07-09Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest’s lead drug candidate SHACT (PDF)
2015-07-07Recipharm Reduces Risk and Improves Compliance with Infor
2015-06-29Recipharm appoints new Sales Director, Development Services (PDF)
2015-06-15Recipharm acquires OnTarget Chemistry and extends its offering into preclinical development services (PDF)
2015-06-05SwedenBio Award2015 (PDF)
2015-06-02Recipharm signs partnership agreement on pharmaceutical development with Follicum (PDF)
2015-06-01Recipharm appoints Chief Strategy Officer (PDF)
2015-05-08Bulletin from Annual General Meeting in Recipharm AB (publ) (PDF)
2015-05-07Interim report January-March 2015 (PDF)
2015-05-05Recipharm publishes Annual report 2014 (PDF)
2015-05-04Invitation to presentation of Recipharm’s interim report for the first quarter on 7 May 2015 (PDF)
2015-04-23Recipharm appoints new General Manager for Recipharm Italia S.p.A (PDF)
2015-04-21Recipharm is commencing negotiations with LIDDS on large-scale manufacture of Liproca® Depot (PDF)
2015-04-14Recipharm makes strategic investment in Synthonics and partners in development of novel compounds (PDF)
2015-04-08Announcement from the nomination committee concerning the Annual General Meeting 2015 (PDF)
2015-03-26Recipharm and Adroit Science form collaboration to expand service offering (PDF)
2015-03-18Recipharm completes Korean serialisation project for Abbott as the CDMO continues international roll out (PDF)
2015-03-10Recipharm appoints new position of Vice President Quality Management (PDF)
2015-02-27Change in the total number of shares and votes in Recipharm AB (publ) (PDF)
2015-02-26Recipharm presents its seventh International Environmental Award winner (PDF)
2015-02-19Full-Year-report January-December 2014 (PDF)
2015-02-16Invitation to presentation of Recipharm’s Full-Year-report for 2014 on 19 February 2015 (PDF)
2015-01-28Recipharm ready for serialisation and delivers complex project for China (PDF)
2015-01-22Recipharm releases the lock-up on 815,000 B-shares related to shares to be issued upon conversion of convertible bonds (PDF)
2015-01-21Recipharm releases the lock-up on 1.3 million B-shares related to shares to be issued upon conversion of convertible bon... (PDF)
2014-12-22Announcement of prospectus regarding the admission to trading of new shares in Recipharm issued in connection with the a... (PDF)
2014-12-04Customer to transfer Swedish penicillin manufacturing (PDF)
2014-12-01Recipharm completes acquisition of Flamel Technologies facility in France (PDF)
2014-11-27Recipharm acquires Flamel Technologies facility and extend development services in France (PDF)
2014-11-19Recipharm sponsors award for best doctoral thesis
2014-11-14Invitation to telephone conference due to Recipharm’s acquisition of Lusomedicamenta (PDF)
2014-11-13Recipharm acquires Lusomedicamenta for SEK 1 billion (PDF)
2014-11-07Interim report January-September 2014 (PDF)
2014-11-05Invitation to presentation of Recipharm’s interim report for the third quarter of 2014 on 7 November (PDF)
2014-10-17The main shareholders implement a division of their shareholdings in Recipharm (PDF)
2014-10-16Recipharm AB's board member won Women's board Award
2014-10-01Recipharm completes acquisition of Corvette Pharmaceutical Services Group for SEK1.1 billion (PDF)
2014-09-24How to implement serialization in practice
2014-09-19Recipharm secures financing for continued growth (PDF)
2014-09-11Resolutions adopted at Extraordinary General Meeting of shareholders of Recipharm AB (publ) (PDF)
2014-08-26Recipharm forms new collaboration with Isofol Medical to exclusively manufacture Modufolin® and invests SEK 8 million in... (PDF)
2014-08-19Recipharm to acquire Corvette Pharmaceutical Services Group for SEK 1.1 billion (PDF)
2014-08-14Interim report January-June 2014 (PDF)
2014-08-14Interim report January - June 2014 (PDF)
2014-08-11Invitation to presentation of Recipharm’s interim report for the second quarter of 2014 on August 14th (PDF)
2014-07-03Gunilla Lundmark Pharmanest (PDF)
2014-06-18Recipharm and CTC forms new collaboration (PDF)
2014-05-08Interim report Q1 front page (PDF)
2014-05-06Invitation to presentation of Recipharm’s interim report for the first quarter of 2014 on May 8
2014-04-30Change in the total number of shares and votes in Recipharm AB (publ) ("Recipharm") (PDF)
2014-04-11Näringslivsmedaljen- LB TE
2014-04-11Exercise of the over-allotment option in relation to shares of series B in Recipharm
2014-04-03Recipharm prices its initial public offering at SEK 78 per share – trading on NASDAQ OMX Stockholm commences today
2014-04-03Thomas Eldered interviewed by EFN
2014-04-03Counterfeit-proof pharmaceutical packaging
2014-04-03Press release - NASDAQ OMX welcomes Recipharm to the main market
2014-04-03Lars Backsell interviewed by EFN
2014-03-24Recipharm Annual report 2013 (PDF)
2014-03-19Recipharm to the stock exchange
2014-03-13Antonio Lopez
2014-03-06Lars Backsell in an interview with Life Science Sweden
2014-02-07Recipharm presents its sixth International Environmental Award winner
2014-02-07The Services business in Sweden revolt in the newly formed network LSIS
2014-02-03Recipharm contributes to setting up a new network within contract-based research, development and manufacture in Sweden (PDF)
2013-12-16Recipharm subsidiary files infectious disease drug application in European markets
2013-10-15Recipharm in new German market collaboration for development services
2013-10-08Recipharm to expand lyophilization capacity with €32 million investment in Germany
2013-09-23Abstral®, manufactured and packaged by Recipharm AB for Kyowa Hakko Kirin, has been approved in Japan
2013-06-11Recipharm AB provides access to Asmasal Clickhaler dossier for Vectura plc Chinese market approval
2013-05-14Recipharm Annual report 2012 (PDF)
2013-05-07Recipharm and Synthonics join forces to promote novel drug delivery technology
2013-03-26Recipharm site in France approved for supply of manufactured products to Japan
2013-02-12Recipharm supplies clinical trial material for FDA approved phase IIb study sponsored by PledPharma
2013-02-05Recipharm Appoints Prof. Hans Lennernäs to one of its operating Boards
2013-01-23Recipharm International Environmental Award 2012 won by Dr. Damià Barceló
2012-12-20flodin ann
2012-12-05Meeting the demands of today's large pharmaceuticals companies
2012-04-25Recipharm Annual report 2011 (PDF)
Brought to you by - Latest Jobs in Pharma
Brought to you by - Latest Jobs in Pharma.